… Atypical lobular hyperplasia and classic lobular carcinoma in situ—ALH and classic LCIS …
than 5%) with small volume lobular neoplasia on CNB in the setting of radiologic-pathologic …

… of atypical lobular hyperplasia and lobular carcinoma in situ. … monitoring with a dedicated
multidisciplinary team to offer the … A full multidisciplinary team is fundamental to focus on all …

… a diagnosis of pure atypical lobular hyperplasia and/or classic lobular carcinoma in situ on
… These data provide reassurance that routine excision of pure LN in the setting of radiologic-…

Purpose The management of biopsy proven atypical lobular hyperplasia (ALH) is controversial.
Although upgrade rates are low, excisional biopsy is often performed to rule out occult …

… B, MRI-guided biopsy yielded fibrocystic change with a single focus of atypical lobular
hyperplasia. This result was felt to not sufficiently explain the mass, and therefore the case was …

… Biopsy-proven breast lesions such as atypical ductal hyperplasia (ADH) or atypical lobular
hyperplasia (ALH), lobular carcinoma in situ (LCIS) and flat epithelial atypia (FEA) increase …

… Opportunities for de-escalation of surgical intervention for BWUP breast lesions exist, and
decisions for when to omit surgery should be made as a multidisciplinary team. The oncologic …

… encompasses both lobular carcinoma in situ (LCIS) and atypical lobular hyperplasia (ALH). …
to be eligible for this approach after multidisciplinary team evaluation (66). Guidelines from …

… Atypical lobular hyperplasia (ALH) and lobular carcinoma in … cells originating in the terminal
duct lobular units (TDLUs), with or … In the core biopsy setting, pathologists are encouraged to …

… of lobular neoplasia (atypical lobular hyperplasia and non–pleomorphic lobular carcinoma in
situ… new diagnosis, after discussion at the multidisciplinary team meeting. All patients with a …